top of page

Profiting From the Dead: When Human Life Becomes a Variable in the Economics of Profit

8 hours ago
5 min read

PROFITING FROM THE DEAD


A Paris apartment that has been a home for decades, where an elderly widow is sitting. It's been sold, yet she still lives there. The buyer pays her monthly. The arrangement can last years, even decades. The buyer cannot move in and has no right to full ownership. He has no idea when the investment will exactly pay off.


Illustration by The Geostrata


A transaction is referred to as a viager; a uniquely French property arrangement in which a buyer of a home pays an upfront sum and monthly payments to the seller for the rest of their life. It is a good idea on the surface for elderly homeowners seeking income without having to leave their homes. But in practice it poses a very awkward question.


The financial result of this agreement is not based on the condition of the property or the state of the market; it's based on the length of another human’s life.

The longer the owner lives, the more the buyer pays. The sooner the seller dies, the sooner the buyer gains complete ownership and the greater the potential return. They make the deal with neither party in the agreement, wishing harm for the other, but the agreement makes it undeniable that human mortality becomes a factor in financial calculation. Perhaps most unsettling is not the fact that such a system is in place but that it is becoming normal.


THE NORMALISATION OF MORTALITY


Many people who support viagers say that it's a win-win situation. For the elderly homeowner, it's a regular income source while remaining in a familiar place, while for the buyer, it's access to a home that may have been difficult to afford otherwise. The system is often seen as a viable, market-orientated answer to demographic aging and increasing housing prices in a country. But, in practice, there are still ethical issues that lie underneath the transaction.


The majority of economic agreements are based on the exchange of goods, services, labour or capital. A viager adds a personal element to the mix: the remaining life of an individual. The life span of the seller is not just a function of health or good fortune; it becomes a financial significance for a stranger. As the seller grows older, the cost rises, and if he dies earlier, the economics of the deal improve for the buyer.


It doesn't take long for system defenders to explain that the buyer doesn't want the seller to die.

That may be true. But intention isn't enough to make something moral. The incentives are what finally determine the economic systems, and with Viager, these interests of the two parties are subtly tied to the death of one of them. That's where the moral discomfort arises.


In modern societies the dignity of human life is generally acknowledged as something beyond monetary valuation. Death is not a business transaction but rather a personal tragedy. Viager seeks to blur that line. It does not celebrate death, but neither is it completely detached from it. Rather, it embodies the mechanism of a financial transaction with the concept of death.


The most troubling of these is the ease of normalisation of this reality. What may have seemed morally dubious is now seen as a mere housing option. As the language of contracts, payments and investment returns permeates, it makes it increasingly difficult to remember that it's always about a profound human uncertainty: how much life is there left to live?


BEYOND VIAGER: PROFITING FROM HUMAN MORTALITY


Had Viager been just a little-known corner of the French real estate market, it might just be a quirky French cultural phenomenon. The truth, however, is more disturbing. Viager is significant not because it is unique or new, but because it is indicative of a broader willingness to embrace economic models in which death has financial value.


A striking illustration emerged in the United States through a form of corporate-owned life insurance, more famously known as "dead peasant insurance." In these schemes, the firms would buy life insurance policies for staff and then receive the proceeds when they died. The policy was legal, and there were often arguments for it being a legitimate financial instrument, but there were questions raised about the ethical dilemmas of such a policy benefitting corporations at the expense of the lives of the individuals whose families were often receiving little to no direct benefit.


The comparison with viager is impossible to ignore. Both the systems are different in form but share the same principle. In both, human life is intertwined with profit. When someone dies, not only is the life ending, but there's also a financial outcome for another party.

The problem is participants don't desire death. Most do not. The problem is that in modern economies, death has gained a measurable monetary value in more and more circumstances. If this is granted, the distinction between human life and economic calculation starts to break down. That's why it is important to keep questioning the ongoing acceptance of viager. France often presents itself as a defender of social solidarity, welfare protections, and human dignity. However, viager is based on a premise that is sitting uneasily with those values. It requires a society to embrace a tradeoff with one person's life expectancy affecting another person's financial success.


The contradiction is hard to ignore. A country which, rightly, condemns the reduction of people to economic units is willing to accept a housing mechanism where financial consequences are attached to the span of a human life. The criticism is not against the elderly seeking financial security, nor the buyers whose housing market is fraught with obstacles. Both are reacting to self-generated incentives. There is a deeper issue of normalising those incentives. But when societies begin to develop financial systems based on the reality of death, they may inadvertently turn death into an economic instrument.


This transformation could be slow and could be concealed under the legal covenants and market jargon. It's still not insignificant, though. A society's values are revealed not only by what it condemns but also by what it chooses to accept as normal.


CONCLUSION: THE PRICE OF HUMAN LIFE


Economies today are amazingly adept at putting a dollar sign on nearly anything. Risk, uncertainty, time and even expectations are priced in the market. But the mortality rate has always had a room of its own, and, indeed, it was not considered an economic variable but rather a personal one.


Viager challenges that distinction. It demands no cruelties, nor does it foster malice. What it does show is, however, a greater acceptance of the uncertainty of human life in the financial calculation. The question is not whether such arrangements are legal or practical; it is what they imply with respect to the values of a society.


Economies are still expanding, questing into new realms of human experience, and it's worth considering whether all life should be turned into a business opportunity. Values are not just what a society shuns but also what it accepts as normal.


BY KAPISH

TEAM GEOSTRATA



Comments


bottom of page